RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Cash from operations

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 202418,806-17.66%
Dec 31, 202322,839-8.44%
Dec 31, 202224,943+9.51%
Dec 31, 202122,777+29.50%
Dec 31, 202017,588+32.00%
Dec 31, 201913,324-0.77%
Dec 31, 201813,427+34.81%
Dec 31, 20179,960+41.46%
Dec 31, 20167,041-6.56%
Dec 31, 20157,535+112.31%
Dec 31, 20143,549-43.37%
Dec 31, 20136,267

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)